Literature DB >> 24358769

[Hyaluronic acid-based carriers for tumor targeted delivery system].

Li-peng Qiu1, Miao-miao Long1, Da-wei Chen1.   

Abstract

Hyaluronic acid (HA) as anticancer drug carrier has become the new hot point in the field of tumor-targeted drugs delivery system in recent years. Tumor therapeutic agents could be transmitted into cells because of hyaluronic acid innate ability to recognize specific cellular receptors that overexpressed on tumor cells surface. This review introduces the basic properties and physiology foundation of hyaluronic acid. Recent research developments based on different forms of HA tumor-targeted drugs delivery systems are reviewed in particular.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24358769

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  1 in total

1.  Hyaluronic acid derivative-modified nano-structured lipid carrier for cancer targeting and therapy.

Authors:  Xiao Liu; Hai Liu; Su-Lan Wang; Jing-Wen Liu
Journal:  J Zhejiang Univ Sci B       Date:  2020-07       Impact factor: 3.066

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.